Skip to main content
. 2024 Jul 23;111(8):1588–1604. doi: 10.1016/j.ajhg.2024.06.015

Table 1.

Clinical findings in individuals with heterozygous de novo HDAC3 variants

Proband Individual 1 Individual 2 Individual 3 Individual 4 Individual 5 Individual 6
mRNA (GenBank: NM_003883.4) c.328G>A c.1075C>T c.277G>A c.797T>C c.799G>A c.601C>T
Protein (GenBank: NP_003874.2) p.Ala110Thr p.Arg359Cys p.Asp93Asn p.Leu266Ser p.Gly267Ser p.Pro201Ser
Ancestry Asian Asian European European European European
Sex female female male female male male
Age at last evaluation 25 years 5 years 6 years 12 years 15 years 12 years
Gestational age at delivery full-term, cesarean delivery 36 weeks, vaginal delivery 40 weeks, vaginal delivery not available 35 weeks, vaginal delivery (dizygotic twin) full-term, vaginal delivery
Birth weight 1.98 kg 2.10 kg 3.30 kg not available 2.04 kg 4.17 kg
Intellectual disability severe severe moderate mild moderate no
Neurodevelopmental delay yes yes yes yes yes no
Musculoskeletal abnormalities scoliosis, varus of the proximal tibia, hand joint deformity polydactyly, syndactyly no joint hypermobility hand joint deformity neonatal torticollis
Seizure yes no yes no no yes
Facial dysmorphism yes yes no no yes no
Brain MRI findings no specific findings no specific findings subcortical heterotopia focus of nodular heterotopia mildly dilated vestibular ducts no specific findings
Genitourinary anomaly no congenital hydronephrosis phimosis no congenital unilateral right hydronephrosis with vesicoureteral reflux no
Microcephaly yes yes no no no no
Hearing impairment sensorineural type no no no mixed type no
Failure to thrive yes yes no no no no
Congenital heart disease yes yes no no no no
Autistic behavior yes no yes no no no
Other findings microtia subcutaneous scalp arteriovenous malformation type 1 diabetes, chronic acral warts